Lotrafiban hydrochloride
- Level
- Commodity
- Parent
- 51131700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131750This classification denotes an antiplatelet agent C23H32N4O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GSV7V79C63, chemically known as (s)-2,3,4,5-tetrahydro-4-methyl-3-oxo-7-((4-(4-piperidyl)piperidino)carbonyl)-1h-1,4-benzodiazepine-2-acetic acid, monohydrochloride, but more generally known as lotrafiban hydrochloride, which bears US NIH Compound Identifier 80275. Most nations, for tariff and trade purposes, schedule lotrafiban hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, LOTRAFIBAN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Lotrafiban hydrochloride bears US NLM identifiers UMLS ID C1259239 and NCI Concept Code C81572. SMILES: CN1CC2CC(CCC2N[C@H](C1=O)CC(=O)O)C(=O)N3CCC(CC3)C4CCNCC4.CL.
Same parent
Under 51131700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.